Fluorescence in vivo imaging provider VisEn Medical Inc. of Bedford, Mass., has announced that it has acquired the fluorescence imaging agent intellectual property portfolios and related technology platforms of Bayer Schering Pharma AG of Berlin. The transaction includes more than 45 issued patents worldwide, covering a range of fluorescence agent constructs and imaging methods, and consolidates VisEn’s patent and technology leadership position in the fluorescence imaging market.
- The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
MORE FROM PHOTONICS MEDIA